FILTER
FILTERED INTERVIEW RESULTS
Philipp Haas
CHAIRMAN & CEO, DEVA HOLDING
Active since 1958, DEVA is a generics company with approximately 600 products ranging from APIs, formulations, sterile injectables and ampoules, BFS eye drops and animal health products.
Faik Somer
CEO, BIRGI MEFAR GROUP
Mefar İlaç San. A.Ş. is a global contract manufacturer offering parenteral solutions such as ampoules, vials, bottles and syringes, alongside development and packaging solutions.
Dr. Okan Oncel
GENERAL MANAGER, BILIM ILAC
Bilim Pharmaceuticals is a 100% Turkish drug manufacturer and marketer and ranked 2nd among 300 corporations in the Turkish pharmaceutical industry.
Turgut Tokgöz
SECRETARY GENERAL, IEIS
IEIS discusses its initiatives to support Turkey’s ascent as a leading pharmaceutical hub and a competitive player in the biopharma space.
Dr. Yormaz Ismail
MANAGING DIRECTOR, RECORDATI İLAÇ SAN. VE TİC. A.Ş.
Headquartered in Milan and with operations around the globe, Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases.
Zeynep Atabay Taşkent & Doğan Taşkent
OWNER & BOARD MEMBER, ATABAY PHARMACEUTICALS AND FINE CHEMICALS
Atabay was founded in Istanbul by Mr. Ö. Kemalettin Atabay in 1939 and today is fully active in producing quality products for human health.
Samir Gandhi & Kartik Gandhi
MANAGING DIRECTOR AND CEO & DIRECTOR, GANDHI AUTOMATIONS
Gandhi Automations is taking a leading role in introducing the benefits of automation to Indian manufacturers – including the pharma industry.
Professor Fazilet Vardar Sukan
DIRECTOR, SUNUM (SABANCI UNIVERSITY)
The Sabanci University Nanotechnology Research and Application Center (SUNUM) brings together researchers with expertise spanning advanced materials, nano-biotechnology, nano-electronics, micro-nano fluidics, micro-nano-electromechanical systems and nano-engineering.
Mohal K Sarabhai
CEO, ASENCE PHARMA PRIVATE LIMITED, (AMBALAL SARABHAI ENTERPRISES LTD (ASE) GROUP)
ASE is one of the oldest pharmaceutical companies in India and re-emerged as a parent company for different subsidiaries.
Ciara Kennedy
PRESIDENT AND CEO, AMPLYX PHARMACEUTICALS
Amplyx Pharmaceuticals has a near-term focus on deadly fungal pathogens in vulnerable, immune-compromised patients.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Mexico Chemicals 2025 CW Release
Mexico's chemical industry faces challenges in securing a reliable feedstock supply and maintaining global competitiveness. A shift towards sustainable energy and local production could provide long-term growth opportunities, and some sectors are booming, including Mexico's dynamic chemical distribution market.
Mexico's chemical industry faces challenges in securing a reliable feedstock supply and maintaining global competitiveness. A shift towards sustainable energy and local production could provide long-term growth opportunities, and some sectors are booming, including Mexico's dynamic chemical distribution market.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
